Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $1.14 Million - $1.53 Million
7,096 Added 12.3%
64,773 $12.3 Million
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $3.02 Million - $4.42 Million
15,561 Added 36.95%
57,677 $11.5 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $267,149 - $331,892
1,523 Added 3.75%
42,116 $9.13 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $401,811 - $583,548
1,966 Added 5.09%
40,593 $8.35 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $1.56 Million - $2.48 Million
-7,987 Reduced 17.13%
38,627 $10.7 Million
Q2 2022

Aug 12, 2022

BUY
$115.91 - $214.48 $526,115 - $973,524
4,539 Added 10.79%
46,614 $8.91 Million
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $660,145 - $1.07 Million
5,159 Added 13.97%
42,075 $8.72 Million
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $216,155 - $316,555
1,309 Added 3.68%
36,916 $6.58 Million
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $89,046 - $127,914
543 Added 1.55%
35,607 $7.33 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $678,413 - $1.04 Million
5,161 Added 17.26%
35,064 $6.65 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $102,930 - $157,675
-1,110 Reduced 3.58%
29,903 $3.9 Million
Q4 2020

Mar 01, 2021

BUY
$67.44 - $103.72 $502,023 - $772,091
7,444 Added 31.58%
31,013 $3.22 Million
Q2 2020

Aug 14, 2020

BUY
$27.25 - $47.53 $410,630 - $716,229
15,069 Added 177.28%
23,569 $1.12 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.74 $196,860 - $405,790
8,500 New
8,500 $282,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.